Laetitia Mauge, PharmD PhD

PharmD, PhD
Service d’Hématologie biologique, AP-HP, Hôpital européen Georges-Pompidou, F-75015, Université Paris Cité, Inserm, PARCC, F-75015 Paris, France

Laetitia MAUGE, PharmD-PhD currently in the Department of Biological Haematology of the Georges Pompidou European Hospital (HEGP), Faculty of Medicine Paris Cité University and PARCC-INSERM U970.
Hospital activity mainly focused on haemostasis with a specialization in the diagnosis of inherited thrombophilia, plasmatic and genetic exploration of antithrombin, proteins C and S deficiencies. Research activity also directed on the role of angiogenesis in the response to antiangiogenic or immunotherapy in renal cancer (in the INSERM U970, team «Immunotherapy and anti-angiogenic treatment in cancer»).
Member of the French Study Group in Haemostasis and the French Society of Angiogenesis .

Presentation(s):

• PB0954 - Thrombotic profile according to antithombin deficiency and SERPINC1 gene analysis: a French retrospective cohort study.

  Monday, July 11, 2022
  6:30 PM – 7:30 PM